A rationally designed anticancer drug targeting a unique binding cavity of tubulin

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 10, 2000, Pages 1015-1018

  Uckun, Fatih M ^a   Mao, Chen ^a   Vassilev, Alexei O ^a   Navara, Christopher S ^a   Narla, Rama Krishna S ^a   Jan, Shyi Tai ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUBULIN; UNCLASSIFIED DRUG; WHI 261;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CELL; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG TARGETING; GLIOBLASTOMA; HEAD; HUMAN; HUMAN CELL; LEUKEMIA CELL; NECK; PROSTATE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; FATTY ALCOHOLS; FURANS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0034658559     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00148-7     Document Type: Article

References (15)

1. Avila J. Life Sci. 50:1992;327.
2. Hyams, J. S.; Lloyd, C. W. Microtubules 1994, New York.
3. Hyman A., Karsenti E. J. Cell Sci. 111:1998;2077.
4. Downing K.H., Nogales E. Curr. Opin. Cell Biol. 10:1998;16.
5. Kozielski F., Arnal I., Wade R.H. Curr. Biol. 8:1998;191.
6. Nogales E., Wolf S.G., Downing K.H. Nature. 391:1998;199.
7. Li, K.; Vig, S.; Uckun, F. Tetrahedron 1998, 39, 2063.
8. Li, K.; Uckun, F. United States Patent No. 5,914,410 (Date of patent: 22 June 1999).
9. Connolly M.L. Science. 221:1983;709.
10. Bacon D.J., Anderson W.F. J. Molec. Graphics. 6:1988;219.
11. Merritt E.A., Murphy M.E.P. Acta Cryst. D50:1994;869.
12. Kraulis P. J. Appl. Cryst. 24:1991;946.
13. Jaing J.D., Davis A.S., Middleton K.M., Bekesi J.O. Cancer Research. 58:1998;5389.
14. Narla R.K., Liu X.P., Klis D., Uckun F.M. Clin Cancer Res. 4:1998;2463.
15. -1.